4CPS-025 Adequacy of hepatitis B reactivation prophylaxis in patients treated with rituximab | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Section 7: Post Congress additions

4CPS-025 Adequacy of hepatitis B reactivation prophylaxis in patients treated with rituximab

Free

Online download statistics by month:

Online download statistics by month: April 2022 to September 2024

	Abstract	Full	Pdf
Apr 2022	38	0	0
May 2022	7	0	9
Jun 2022	4	0	0
Jul 2022	31	0	6
Aug 2022	6	0	0
Sep 2022	18	0	0
Oct 2022	46	0	7
Nov 2022	25	0	1
Dec 2022	16	0	0
Jan 2023	16	0	1
Feb 2023	8	0	2
Mar 2023	6	0	3
Apr 2023	18	0	1
May 2023	4	0	0
Jun 2023	4	0	0
Jul 2023	21	0	2
Aug 2023	6	0	2
Sep 2023	10	0	1
Oct 2023	6	0	1
Nov 2023	9	0	1
Dec 2023	4	0	3
Jan 2024	2	0	1
Feb 2024	4	0	3
Mar 2024	21	0	2
Apr 2024	15	0	9
May 2024	32	0	2
Jun 2024	19	0	0
Jul 2024	5	0	3
Aug 2024	2	0	1
Sep 2024	18	0	0
Total	421	0	61